Lilly seeks investors to expand subsidiary's portfolio

11/4/2009 | Wall Street Journal, The

Eli Lilly and Co. plans to increase funds and put more drug candidates into its subsidiary Chorus, a company executive said. The drugmaker is looking for financial backers rather than pharmaceutical partners to maintain its control over Chorus' early- and late-stage drug development, said Gino Santini, Lilly's senior vice president of corporate strategy and business development.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC